172 related articles for article (PubMed ID: 24014739)
1. Concurrent overexpression of RET/PTC1 and TTF1 confers tumorigenicity to thyrocytes.
Endo T; Kobayashi T
Endocr Relat Cancer; 2013 Dec; 20(6):767-76. PubMed ID: 24014739
[TBL] [Abstract][Full Text] [Related]
2. Role of H2O2 in RET/PTC1 chromosomal rearrangement produced by ionizing radiation in human thyroid cells.
Ameziane-El-Hassani R; Boufraqech M; Lagente-Chevallier O; Weyemi U; Talbot M; Métivier D; Courtin F; Bidart JM; El Mzibri M; Schlumberger M; Dupuy C
Cancer Res; 2010 May; 70(10):4123-32. PubMed ID: 20424115
[TBL] [Abstract][Full Text] [Related]
3. RET/papillary thyroid cancer rearrangement in nonneoplastic thyrocytes: follicular cells of Hashimoto's thyroiditis share low-level recombination events with a subset of papillary carcinoma.
Rhoden KJ; Unger K; Salvatore G; Yilmaz Y; Vovk V; Chiappetta G; Qumsiyeh MB; Rothstein JL; Fusco A; Santoro M; Zitzelsberger H; Tallini G
J Clin Endocrinol Metab; 2006 Jun; 91(6):2414-23. PubMed ID: 16595592
[TBL] [Abstract][Full Text] [Related]
4. Early cellular abnormalities induced by RET/PTC1 oncogene in thyroid-targeted transgenic mice.
Cho JY; Sagartz JE; Capen CC; Mazzaferri EL; Jhiang SM
Oncogene; 1999 Jun; 18(24):3659-65. PubMed ID: 10380889
[TBL] [Abstract][Full Text] [Related]
5. Real-time quantitative RT-PCR identifies distinct c-RET, RET/PTC1 and RET/PTC3 expression patterns in papillary thyroid carcinoma.
Rhoden KJ; Johnson C; Brandao G; Howe JG; Smith BR; Tallini G
Lab Invest; 2004 Dec; 84(12):1557-70. PubMed ID: 15502856
[TBL] [Abstract][Full Text] [Related]
6. Establishment of a non-tumorigenic papillary thyroid cell line (FB-2) carrying the RET/PTC1 rearrangement.
Basolo F; Giannini R; Toniolo A; Casalone R; Nikiforova M; Pacini F; Elisei R; Miccoli P; Berti P; Faviana P; Fiore L; Monaco C; Pierantoni GM; Fedele M; Nikiforov YE; Santoro M; Fusco A
Int J Cancer; 2002 Feb; 97(5):608-14. PubMed ID: 11807785
[TBL] [Abstract][Full Text] [Related]
7. Diffuse sclerosing variant of papillary thyroid carcinoma: major genetic alterations and prognostic implications.
Joung JY; Kim TH; Jeong DJ; Park SM; Cho YY; Jang HW; Jung YY; Oh YL; Yim HS; Kim YL; Chung JH; Ki CS; Kim SW
Histopathology; 2016 Jul; 69(1):45-53. PubMed ID: 26568156
[TBL] [Abstract][Full Text] [Related]
8. Papillary thyroid carcinoma: 6 cases from 2 families with associated lymphocytic thyroiditis harbouring RET/PTC rearrangements.
Mechler C; Bounacer A; Suarez H; Saint Frison M; Magois C; Aillet G; Gaulier A
Br J Cancer; 2001 Dec; 85(12):1831-7. PubMed ID: 11747322
[TBL] [Abstract][Full Text] [Related]
9. Activation of signal transducer and activator of transcription 3 by oncogenic RET/PTC (rearranged in transformation/papillary thyroid carcinoma) tyrosine kinase: roles in specific gene regulation and cellular transformation.
Hwang JH; Kim DW; Suh JM; Kim H; Song JH; Hwang ES; Park KC; Chung HK; Kim JM; Lee TH; Yu DY; Shong M
Mol Endocrinol; 2003 Jun; 17(6):1155-66. PubMed ID: 12637586
[TBL] [Abstract][Full Text] [Related]
10. Low prevalence of RET rearrangements (RET/PTC1, RET/PTC2, RET/PTC3, and ELKS-RET) in sporadic papillary thyroid carcinomas in Taiwan Chinese.
Liu RT; Chou FF; Wang CH; Lin CL; Chao FP; Chung JC; Huang CC; Wang PW; Cheng JT
Thyroid; 2005 Apr; 15(4):326-35. PubMed ID: 15876154
[TBL] [Abstract][Full Text] [Related]
11. Synthesis, characterization, and in vivo delivery of siRNA-squalene nanoparticles targeting fusion oncogene in papillary thyroid carcinoma.
Raouane M; Desmaele D; Gilbert-Sirieix M; Gueutin C; Zouhiri F; Bourgaux C; Lepeltier E; Gref R; Ben Salah R; Clayman G; Massaad-Massade L; Couvreur P
J Med Chem; 2011 Jun; 54(12):4067-76. PubMed ID: 21561161
[TBL] [Abstract][Full Text] [Related]
12. Creation and characterization of a doxycycline-inducible mouse model of thyroid-targeted RET/PTC1 oncogene and luciferase reporter gene coexpression.
Knostman KA; Venkateswaran A; Zimmerman B; Capen CC; Jhiang SM
Thyroid; 2007 Dec; 17(12):1181-8. PubMed ID: 18004977
[TBL] [Abstract][Full Text] [Related]
13. [Expressions of wildtype-RET and RET/PTC rearrangements in sporadic adult papillary thyroid carcinoma and their clinicopathologic correlation].
Zhu XL; Zhou XY; Zhang TM; Zhu XZ
Zhonghua Bing Li Xue Za Zhi; 2006 Feb; 35(2):87-91. PubMed ID: 16630482
[TBL] [Abstract][Full Text] [Related]
14. RET/PTC1-driven neoplastic transformation and proinvasive phenotype of human thyrocytes involve Met induction and beta-catenin nuclear translocation.
Cassinelli G; Favini E; Degl'Innocenti D; Salvi A; De Petro G; Pierotti MA; Zunino F; Borrello MG; Lanzi C
Neoplasia; 2009 Jan; 11(1):10-21. PubMed ID: 19107227
[TBL] [Abstract][Full Text] [Related]
15. MEK inhibitor PD0325901 significantly reduces the growth of papillary thyroid carcinoma cells in vitro and in vivo.
Henderson YC; Chen Y; Frederick MJ; Lai SY; Clayman GL
Mol Cancer Ther; 2010 Jul; 9(7):1968-76. PubMed ID: 20587665
[TBL] [Abstract][Full Text] [Related]
16. The roles of phosphotyrosines-294, -404, and -451 in RET/PTC1-induced thyroid tumor formation.
Buckwalter TL; Venkateswaran A; Lavender M; La Perle KM; Cho JY; Robinson ML; Jhiang SM
Oncogene; 2002 Nov; 21(53):8166-72. PubMed ID: 12444552
[TBL] [Abstract][Full Text] [Related]
17. RET/PTC1 oncogene signaling in PC Cl 3 thyroid cells requires the small GTP-binding protein Rho.
Barone MV; Sepe L; Melillo RM; Mineo A; Santelli G; Monaco C; Castellone MD; Tramontano D; Fusco A; Santoro M
Oncogene; 2001 Oct; 20(48):6973-82. PubMed ID: 11704822
[TBL] [Abstract][Full Text] [Related]
18. The RET/PTC3 oncogene: metastatic solid-type papillary carcinomas in murine thyroids.
Powell DJ; Russell J; Nibu K; Li G; Rhee E; Liao M; Goldstein M; Keane WM; Santoro M; Fusco A; Rothstein JL
Cancer Res; 1998 Dec; 58(23):5523-8. PubMed ID: 9850089
[TBL] [Abstract][Full Text] [Related]
19. Thyroid carcinomas in RET/PTC transgenic mice.
Jhiang SM; Cho JY; Furminger TL; Sagartz JE; Tong Q; Capen CC; Mazzaferri EL
Recent Results Cancer Res; 1998; 154():265-70. PubMed ID: 10027006
[TBL] [Abstract][Full Text] [Related]
20. RET/PTC activation in hyalinizing trabecular tumors of the thyroid.
Papotti M; Volante M; Giuliano A; Fassina A; Fusco A; Bussolati G; Santoro M; Chiappetta G
Am J Surg Pathol; 2000 Dec; 24(12):1615-21. PubMed ID: 11117781
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
